|
|
||||||||
The Journal of Immunology, Vol 156, Issue 2 711-718, Copyright © 1996 by American Association of Immunologists
ARTICLES |
ME Bates, PJ Bertics and WW Busse
Department of Medicine, University of Wisconsin, Madison 53792, USA.
IL-5 is a member of the hemopoietic cytokine family and has profound effects on the differentiation, survival, migration, and effector function of human eosinophils. Increased tyrosine phosphorylation has been observed as an early event in IL-5 signal transduction in eosinophils; most notably, proteins of 45 and 135 kDa became tyrosine phosphorylated following IL-5 treatment. Some of these phosphotyrosine- containing proteins may represent intermediates in IL-5 signal transduction pathways. This study demonstrates that Jak-2, a tyrosine kinase, is increasingly tyrosine phosphorylated after IL-5 treatment of human eosinophils. Furthermore, we found proteins of 42, 44, and 45 kDa immunoreactive with anti-mitogen-activated protein (MAP) kinase Abs that are expressed in human eosinophils. One of these, the protein of approximately 45 kDa (p45), was tyrosine phosphorylated following treatment of eosinophils with IL-5 and PMA, as seen by anti- phosphotyrosine immunoprecipitation and immunoblotting with anti-MAP kinase Abs. In addition, anti-phosphotyrosine immunoprecipitates of IL- 5-treated eosinophils contained enhanced phosphotransferase activity toward a myelin basic protein (MBP) peptide substrate when compared with control-treated eosinophils. In contrast to cytokine-stimulated MAP kinase activation in other cells, there is no evidence of tyrosine phosphorylation or enzymatic activation of p42 MAP kinase in eosinophils after IL-5 treatment. These data suggest that Jak-2 kinase and an activated isoform of MAP kinase, p45, are detected following incubation with IL-5, and may mediate some of this cytokine's effects on eosinophils in a manner unique to the activation pathways previously described for other cells.
This article has been cited by other articles:
![]() |
C. K. Wong, W. K. Ip, and C. W. K. Lam Interleukin-3, -5, and Granulocyte Macrophage Colony-Stimulating Factor-Induced Adhesion Molecule Expression on Eosinophils by p38 Mitogen-Activated Protein Kinase and Nuclear Factor-{kappa}B Am. J. Respir. Cell Mol. Biol., July 1, 2003; 29(1): 133 - 147. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Esnault and J. S. Malter Extracellular signal-regulated kinase mediates granulocyte-macrophage colony-stimulating factor messenger RNA stabilization in tumor necrosis factor-alpha plus fibronectin-activated peripheral blood eosinophils Blood, May 13, 2002; 99(11): 4048 - 4052. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Crosby, H. H. Shen, M. T. Borchers, J. P. Justice, T. Ansay, J. J. Lee, and N. A. Lee Ectopic expression of IL-5 identifies an additional CD4+ T cell mechanism of airway eosinophil recruitment Am J Physiol Lung Cell Mol Physiol, January 1, 2002; 282(1): L99 - L108. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Temple, E. Allen, J. Fordham, S. Phipps, H.-C. Schneider, K. Lindauer, I. Hayes, J. Lockey, K. Pollock, and R. Jupp Microarray Analysis of Eosinophils Reveals a Number of Candidate Survival and Apoptosis Genes Am. J. Respir. Cell Mol. Biol., October 1, 2001; 25(4): 425 - 433. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Hall, J. Cui, M. E. Bates, B. A. Stout, L. Koenderman, P. J. Coffer, and P. J. Bertics Transduction of a dominant-negative H-Ras into human eosinophils attenuates extracellular signal-regulated kinase activation and interleukin-5-mediated cell viability Blood, October 1, 2001; 98(7): 2014 - 2021. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bhattacharya, B. A. Stout, M. E. Bates, P. J. Bertics, and J. S. Malter Granulocyte Macrophage Colony-Stimulating Factor and Interleukin-5 Activate STAT5 and Induce CIS1 mRNA in Human Peripheral Blood Eosinophils Am. J. Respir. Cell Mol. Biol., March 1, 2001; 24(3): 312 - 316. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-M. Huang, C.-J. Huang, and J. J.-Y. Yen Mcl-1 is a common target of stem cell factor and interleukin-5 for apoptosis prevention activity via MEK/MAPK and PI-3K/Akt pathways Blood, September 1, 2000; 96(5): 1764 - 1771. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Bates, V. L. Green, and P. J. Bertics ERK1 and ERK2 Activation by Chemotactic Factors in Human Eosinophils Is Interleukin 5-dependent and Contributes to Leukotriene C4 Biosynthesis J. Biol. Chem., April 6, 2000; 275(15): 10968 - 10975. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kankaanranta, P. M. De Souza, P. J. Barnes, M. Salmon, M. A. Giembycz, and M. A. Lindsay SB 203580, an Inhibitor of p38 Mitogen-Activated Protein Kinase, Enhances Constitutive Apoptosis of Cytokine-Deprived Human Eosinophils J. Pharmacol. Exp. Ther., August 1, 1999; 290(2): 621 - 628. [Abstract] [Full Text] |
||||
![]() |
M. A. Giembycz and M. A. Lindsay Pharmacology of the Eosinophil Pharmacol. Rev., June 1, 1999; 51(2): 213 - 340. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Barnes, K. F. Chung, and C. P. Page Inflammatory Mediators of Asthma: An Update Pharmacol. Rev., December 1, 1998; 50(4): 515 - 596. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Adachi and R. Alam The mechanism of IL-5 signal transduction Am J Physiol Cell Physiol, September 1, 1998; 275(3): C623 - C633. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Cortegano, V. del Pozo, B. Cardaba, B. de Andres, S. Gallardo, A. del Amo, I. Arrieta, A. Jurado, P. Palomino, F.-T. Liu, et al. Galectin-3 Down-Regulates IL-5 Gene Expression on Different Cell Types J. Immunol., July 1, 1998; 161(1): 385 - 389. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Wang, P. Wu, B. Cheewatrakoolpong, J. G. Myers, R. W. Egan, and M. M. Billah Selective Inhibition of IL-5 Receptor {alpha}-Chain Gene Transcription by IL-5, IL-3, and Granulocyte-Macrophage Colony-Stimulating Factor in Human Blood Eosinophils J. Immunol., May 1, 1998; 160(9): 4427 - 4432. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ogata, T. Kouro, A. Yamada, M. Koike, N. Hanai, T. Ishikawa, and K. Takatsu JAK2 and JAK1 Constitutively Associate With an Interleukin-5 (IL-5) Receptor alpha and beta c Subunit, Respectively, and Are Activated Upon IL-5 Stimulation Blood, April 1, 1998; 91(7): 2264 - 2271. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Coffer, R. C. Schweizer, G. R. Dubois, T. Maikoe, J.-W. J. Lammers, and L. Koenderman Analysis of Signal Transduction Pathways in Human Eosinophils Activated by Chemoattractants and the T-Helper 2-Derived Cytokines Interleukin-4 and Interleukin-5 Blood, April 1, 1998; 91(7): 2547 - 2557. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Bates, W. W. Busse, and P. J. Bertics Interleukin 5 Signals through Shc and Grb2 in Human Eosinophils Am. J. Respir. Cell Mol. Biol., January 1, 1998; 18(1): 75 - 83. [Abstract] [Full Text] |
||||
![]() |
T. Horiuchi and P. F. Weller Expression of Vascular Endothelial Growth Factor by Human Eosinophils: Upregulation by Granulocyte Macrophage Colony-stimulating Factor and Interleukin-5 Am. J. Respir. Cell Mol. Biol., July 1, 1997; 17(1): 70 - 77. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |